ACLY and autoimmune polyendocrinopathy: Antiphospholipid syndrome (APS) is a pro-thrombotic and inflammatory condition characterized by thromboembolic events or obstetric complications combined with the presence of at least one antiphospholipid antibody (aPL): lupus anticoagulant (LAC), anticardiolipin (aCL) or anti-β2glycoprotein I (aβ2GP1).1